Buy Breo Ellipta (Fluticasone Furoate/Vilanterol Trifenatate) Online From Medications Canada.

BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL INHALATION POWDER) INDICATIONS

Breo Ellipta is a combination of inhaled corticosteroid (ICS) and long-acting beta-2 adrenergic agonist (LABA). It is an oral inhalation powder used as a long-term daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), and it decreases flare-ups. In addition, this inhaler helps treat patients with asthma  18 years and older.

Breo Ellipta inhalation powder consists of two active ingredients that function effectively together in controlling and preventing the narrowing of the airways.

Fluticasone furoate is a corticosteroid that has anti-inflammatory and vasoconstrictive properties. After inhaling Breo Ellipta medication, it prevents the release of inflammatory cells and mediators that can cause inflammation. Hence, it helps reduce airway irritation and help improve lung functioning.

Vilanterol is a long-acting beta-2 adrenergic agonist (LABA) that helps stimulate the beta-2 receptors in the smooth muscles of the lungs, which leads to opening of the airways in the lungs.

In addition, vilanterol inhibits mast cells from releasing mediators that can cause inflammation. Hence, the smooth muscles in the lungs relax, allowing for better breathing, and alleviating wheezing, shortness of breath, and chest tightness associated with COPD.

BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL INHALATION POWDER) USES AND DOSAGE

Breo Ellipta is a dry powder inhaler with the following uses and doses:

• Maintenance treatment for COPD (e.g., chronic bronchitis, emphysema, or both)

The recommended dosage is to administer one inhalation by mouth once daily for 24 hours or as prescribed by your doctor.

• Treatment of asthma in patients 18 years and up

The suggested dose is to administer one inhalation by mouth once daily for 24 hours or as prescribed by your doctor.

Note that Breo Ellipta inhaler comes in a foil tray and contains 30 doses. Every time you fully open the cover, you are preparing one dose of this inhalation, and the counter counts down each time you open it.

To use the Breo Ellipta inhaler, use the following steps:

1. Wash your hands.
2. Slide the cover downward to expose the mouthpiece until you hear a click. The inhaler is now ready to be used.
3. Before using Breo Ellipta inhaler, exhale fully.
4. Place the mouthpiece in your mouth and lock your lips firmly around it.
5. Breathe in (inhale) deeply through your mouth. Make sure not to block the air vent with your fingers
6. Remove the inhaler from your mouth.
7. Hold your breath for at least three to four seconds
8. Slowly breathe out through your nose
9. Clean the mouthpiece with a dry tissue and close the cover.
10. Slide the cover upward to cover the mouthpiece
11. After using the inhaler, rinse your mouth with water and spit the water out.

SIDE EFFECTS OF BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL INHALATION POWDER)

Breo Ellipta inhalation powder may have unwanted side effects similar to other medications that may resolve over time when your body has adjusted to the medicine.

The following are the common side effects of Breo Ellipta that can occur after using this inhaler: 

• Runny nose
• Sore throat
• Upper respiratory tract infection
• Headache
• Oral thrush
• Pneumonia
• Bronchitis (infection of the bronchi)
• Sinusitis (infection of the sinuses)
• Cough
• Pain (back, mouth, throat, joint)
• Increased blood pressure
• Flu
• Fever
• Hoarseness
• Voice changes

SERIOUS SIDE EFFECTS

• Weakened immune system (immunosuppression)
• Adrenal insufficiency
  • Feeling tired
  • Nausea and vomiting
  • Lack of energy
  • Low blood pressure
• Sudden breathing problems
• Chest pain
• Fast, irregular heart rate
• Increased blood pressure
• Tremor
• Nervousness
• Bone weakness (osteoporosis)
• Eye problems (e.g., glaucoma, cataract)
• Delayed growth (children)
• Changes in laboratory blood levels

ALLERGIC REACTIONS

• Skin rash
• Hives
• Skin blisters or peeling
• Swelling (face/tongue/throat)
• Trouble breathing or swallowing

Note that this list does not include all the drug information and health implications related to Breo Ellipta. If you experience other side effects not listed above, consult your healthcare provider for additional information.

BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL INHALATION POWDER) CAUTIONS

Before using Breo Ellipta oral inhalation powder, make sure that you have fully disclosed your medical history to your doctor, especially if you have the following conditions, to know if this inhaler is safe for you:

• Heart problems
• High blood pressure (hypertension)
• Seizures
• Thyroid problems
• Diabetes
• Liver disease
• Weak bones (osteoporosis)
• Immune system problems
• Eye problems (e.g., glaucoma, cataracts)
• Exposure to chicken pox and measles
• Have any kind of infection (viral, bacterial, fungal, or parasite)
• Pregnant or trying to become pregnant
• Breastfeeding

Do not use Breo Ellipta oral inhalation if you have a known allergy to fluticasone furoate, vilanterol, milk protein, or any other components. Make sure to keep an eye out for any allergic reactions while using this inhaler.

Do not use Breo Ellipta inhaler to treat sudden and severe asthmatic or COPD symptoms.

Inform your doctor if you are taking medicines, such as antifungal or anti-HIV, to avoid unwanted drug interactions.

Be cautious when using Breo Ellipta inhaler in patients with asthma, as this may increase the chance of death from asthma problems.

Call your doctor right away if breathing problems worsen over time when using Breo Ellipta oral inhalation.

Keep this Breo Ellipta inhalation powder out of reach of the children and store it safely.

BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL INHALATION POWDER) FORM AND STRENGTH

Breo Ellipta medicine is available in powder inhalation formulation with the following strength:

• BREO ELLIPTA
  • 100/25 mcg powder inhalation
  • 200/25 mcg powder inhalation

FAQ

Is Breo Ellipta inhalation powder a steroid?

Yes, Breo Ellipta oral medication is a combination of inhaled corticosteroid (ICS) and long-acting beta-2 adrenergic agonist (LABA).

What does Breo Ellipta inhalation powder do for you?

The two active ingredients work effectively together in controlling and preventing the constriction of the smooth muscles of the airways. The ICS has anti-inflammatory and vasoconstrictive property that helps reduce airway irritation. Meanwhile, LABA relaxes smooth muscles in the lungs. As a result, Breo Ellipta inhaler improves better lung functioning.

How long should I use Breo Ellipta inhalation powder?

Breo Ellipta inhaler functions as a preventative medication, which means that Breo Ellipta is only beneficial while you are using it. Make sure to continue using Breo Ellipta unless your doctor instructs you to stop, as your symptoms could recur or acute symptoms of asthma or COPD may develop.